Piscataway, NJ, United States of America

Mary A Talle


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1988-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Mary A Talle

Introduction

Mary A Talle is a notable inventor based in Piscataway, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins and monoclonal antibody therapies. With a total of two patents to her name, her work has had a profound impact on medical science.

Latest Patents

Her latest patents include "Recombinant human thymopoietin proteins and uses therefor," which provides novel nucleotide and amino acid sequences for human thymopoietin alpha, beta, and gamma. This invention outlines methods for recombinantly expressing these proteins and their diagnostic and therapeutic uses. Another significant patent is for "Monoclonal antibody therapy," which discloses a method of seriatim administration to a patient of a plurality of ligands, each containing an antigen combining site of a monoclonal antibody of distinct idiotype. This method is beneficial for both therapeutic and diagnostic purposes.

Career Highlights

Throughout her career, Mary has worked with reputable organizations such as Ortho Pharmaceutical Corporation and Immunobiology Research Institute, Inc. Her experience in these companies has allowed her to develop her innovative ideas and contribute to advancements in medical therapies.

Collaborations

Mary has collaborated with notable individuals in her field, including Gideon Goldstein and Walter Newman. These partnerships have further enhanced her research and development efforts.

Conclusion

Mary A Talle's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…